Table 4.
Factor | Number | Median survival, months | p Value |
---|---|---|---|
Age (continuous)a | 95 | 0.42 | |
Gender | |||
Male | 53 | 41.7 | 0.30 |
Female | 42 | 50.1 | |
Tumor type | |||
Carcinoid | 57 | 45.0 | 0.84 |
Islet cell | 38 | 32.0 | |
Disease presentation | |||
Synchronous | 77 | 37.0 | 0.53 |
Metachronous | 18 | 48.7 | |
Liver involvement | |||
Unilobar | 8 | 81.6 | 0.47 |
Bilobar | 87 | 41.8 | |
Primary tumor resection | |||
Yes | 55 | 73.1 | 0.0002 |
No | 39 | 28.0 | |
Resection/ablation mets | |||
Yes | 22 | 65.6 | 0.11 |
No | 73 | 36.5 | |
Octreotide | |||
Yes | 46 | 48.6 | 0.85 |
No | 37 | 37.0 | |
Chemotherapy | |||
Yes | 25 | 39.1 | 0.71 |
No | 50 | 43.0 | |
Embolization type | |||
HACE | 46 | 50.1 | 0.62 |
HAE | 49 | 39.1 |
Significant values in bold type.
Log transformation